Search Results 501-510 of 18128 for sterility

1. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

   Females who are not of childbearing potential (i.e., who are postmenopausal or surgically sterile) and azoospermic males do not require contraception.

2. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer - Mayo Clinic

   Documented surgically sterile. If of childbearing potential. Agree to not try to become pregnant during the study and for 28 days after the final study drug ...

3. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

   Female patients are either postmenopausal for at least 1 year, are surgically sterile for at least 6 weeks, or must agree to take appropriate precautions to ...

4. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

   ... sterile, or abstain from heterosexual activity for the course of the study through 120 days after the last dose of study medication. NOTE: Patients of ...

5. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies - Mayo Clinic

   INR and APTT ≤ 1.5 x ULN. Female subjects of childbearing potential and non-sterile males must practice at least one of the following methods of birth ...

6. A Study to Evaluate the Safety and Effectiveness of AK002 in Patients with Active Eosinophilic Gastritis - Mayo Clinic

   Female patients must be either post-menopausal for at least 1 year with FSH level > 30 mIU/mL at screening or surgically sterile (tubal ligation ...

7. Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) - Mayo Clinic

   Females of childbearing potential must have a negative pregnancy test at Screening (unless surgically sterile or post menopausal) and must agree to use ...

8. A Study to Evaluate PDS0101 and Pembrolizumab Combination to Treat Subjects with HPV16 + Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   sterile or at least 2 years postmenopausal do not require pregnancy testing. Note: Female subjects of childbearing potential must be willing to use an ...

9. A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma - Mayo Clinic

   Female participants of childbearing potential should have a negative pregnancy test and be willing to use 2 methods of birth control or be surgically sterile ...

10. Sperm: How long do they live after ejaculation? - Mayo Clinic

    Sperm typically can stay alive for about 3 to 5 days within the cervix, uterus and fallopian tubes. It's possible for an egg to be fertilized at any point ...